simendan has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HT; Chen, CH; Chen, YL; Chiang, JY; Sung, PH; Yang, CC; Yip, HK | 1 |
| Abdelrahman, AM; Al Salam, S; Al Suleimani, Y; Ali, BH; Ashique, M; Manoj, P | 1 |
| Andersson, KB; Christensen, G; Golz, S; Hillestad, V; Knorr, A; Kramer, F | 1 |
3 other study(ies) available for simendan and Cirrhosis
| Article | Year |
|---|---|
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.
Topics: Aminobutyrates; Animals; Apoptosis; Biphenyl Compounds; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Combinations; Fibrosis; Humans; Inflammation; Kidney; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Simendan; Stroke Volume; Valsartan; Ventricular Function, Left | 2022 |
Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cardiotonic Agents; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Kidney; Male; Oxidative Stress; Polyuria; Rats; Rats, Sprague-Dawley; Simendan | 2020 |
Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Topics: Animals; Calcium Signaling; Cardiotonic Agents; Diastole; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Heart Failure; Hydrazones; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Pyridazines; Recovery of Function; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Stroke Volume; Systole; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2013 |